GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » China Jo-Jo Drugstores Inc (FRA:7QL) » Definitions » YoY EBITDA Growth

China Jo-Jo Drugstores (FRA:7QL) YoY EBITDA Growth : -117.93% (As of Sep. 2023)


View and export this data going back to 2010. Start your Free Trial

What is China Jo-Jo Drugstores YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. China Jo-Jo Drugstores's YoY EBITDA Growth for the quarter that ended in Sep. 2023 was -117.93%.

China Jo-Jo Drugstores's EBITDA per Share for the six months ended in Sep. 2023 was €-8.80.


China Jo-Jo Drugstores YoY EBITDA Growth Historical Data

The historical data trend for China Jo-Jo Drugstores's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Jo-Jo Drugstores YoY EBITDA Growth Chart

China Jo-Jo Drugstores Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 103.10 -770.97 -25.46 90.01 -1,106.83

China Jo-Jo Drugstores Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 231.24 78.99 1,676.09 -170.00 -117.93

China Jo-Jo Drugstores YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

China Jo-Jo Drugstores's YoY EBITDA Growth for the fiscal year that ended in Mar. 2023 is calculated as:

YoY EBITDA Growth (A: Mar. 2023 )
=(EBITDA per Share (A: Mar. 2023 )-EBITDA per Share (A: Mar. 2022 ))/ | EBITDA per Share (A: Mar. 2022 ) |
=(-36.555--3.029)/ | -3.029 |
=-1,106.83 %

China Jo-Jo Drugstores's YoY EBITDA Growth for the quarter that ended in Sep. 2023 is calculated as:

YoY EBITDA Growth (Q: Sep. 2023 )
=(EBITDA per Share (Q: Sep. 2023 )-EBITDA per Share (Q: Sep. 2022 )) / | EBITDA per Share (Q: Sep. 2022 )) |
=(-8.8-49.091)/ | 49.091 |
=-117.93 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


China Jo-Jo Drugstores YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of China Jo-Jo Drugstores's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


China Jo-Jo Drugstores (FRA:7QL) Business Description

Traded in Other Exchanges
Address
386 Shangtang Road, Hai Wai Hai Tongxin Mansion Floor 6, Gong Shu District, Zhejiang Province, Hangzhou, CHN, 310008
China Jo-Jo Drugstores Inc is a retailer and distributor of pharmaceutical products. The company's operating segments include Retail drugstores, Online Pharmacy, Drug wholesale, and Herb farming. Retail drugstores segment sells prescription and over-the-counter medicines, TCM, dietary supplements, medical devices, and sundry items to retail customers. The online pharmacy segment sells drugs through third-party platforms such as Alibaba's Tmall, JD.com, and Amazon.com. It generates maximum revenue from the Retail drugstores segment.

China Jo-Jo Drugstores (FRA:7QL) Headlines

No Headlines